Keyphrases
ATP Binding Cassette Subfamily B Member 1 (ABCB1)
100%
Drug Transporters
100%
ABCG2
100%
Brain Disposition
100%
Spleen Tyrosine Kinase Inhibitor
100%
Entospletinib
100%
Cytochrome P450 3A (CYP3A)
42%
Brain-to-plasma Ratio
28%
Plasma Exposure
28%
Highly Selective
14%
Orally Administered
14%
P-glycoprotein (P-gp)
14%
Mouse Model
14%
Kinase Activity
14%
Pharmacokinetics
14%
Experimental Animals
14%
Wild Mice
14%
Drug Interactions
14%
Female Mice
14%
Animal Handling
14%
Acute Toxicity
14%
Plasma Pharmacokinetics
14%
Uptake Transporter
14%
Elacridar
14%
B-cell Malignancies
14%
Immune Cell Function
14%
Drug-metabolizing Enzymes
14%
Experimental Sample
14%
Brain Penetration
14%
ABCG2 Inhibitor
14%
Human CYP3A4
14%
Oral Pharmacokinetics
14%
Autoimmunity Disease
14%
Beta Cell Autoimmunity
14%
Specimen Preparation
14%
Pharmacology, Toxicology and Pharmaceutical Science
Lanraplenib
100%
Entospletinib
100%
Effusion
100%
ABCG2
100%
Protein Kinase Syk Inhibitor
100%
Pharmacokinetics
37%
CYP3A
25%
Mouse Model
12%
Experimental Animal
12%
Wild Type Mouse
12%
Drug-Drug Interaction
12%
Acute Toxicity
12%
CYP3A4
12%
Phosphotransferase
12%
Elacridar
12%
Drug Metabolizing Enzyme
12%
Diseases
12%